Adial Pharmaceuticals Files 8-K on Financials

Ticker: ADIL · Form: 8-K · Filed: May 15, 2025 · CIK: 1513525

Adial Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyAdial Pharmaceuticals, Inc. (ADIL)
Form Type8-K
Filed DateMay 15, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations

TL;DR

Adial Pharma dropped an 8-K, check their financials.

AI Summary

Adial Pharmaceuticals, Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report date and date as of change both being May 15, 2025. The company is incorporated in Delaware and its principal executive offices are located in Glen Allen, VA.

Why It Matters

This filing provides an update on Adial Pharmaceuticals' financial performance and condition, which is crucial for investors to assess the company's stability and future prospects.

Risk Assessment

Risk Level: medium — 8-K filings can contain significant financial or operational updates that may impact a company's stock price, requiring careful review.

Key Players & Entities

  • Adial Pharmaceuticals, Inc. (company) — Registrant
  • May 15, 2025 (date) — Report Date
  • Delaware (jurisdiction) — State of Incorporation
  • Glen Allen, VA (location) — Principal Executive Offices

FAQ

What specific financial information is being reported in this 8-K filing?

The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was this 8-K report filed and what is the earliest event date reported?

The report was filed on May 15, 2025, and the earliest event date reported is also May 15, 2025.

What is Adial Pharmaceuticals, Inc.'s state of incorporation and IRS Employer Identification Number?

Adial Pharmaceuticals, Inc. is incorporated in Delaware and its IRS Employer Identification Number is 82-3074668.

Where are Adial Pharmaceuticals, Inc.'s principal executive offices located?

The principal executive offices are located at 4870 Sadler Road, Ste 300, Glen Allen, VA 23060.

Has Adial Pharmaceuticals, Inc. undergone any previous name changes?

Yes, the company was formerly known as Adial Pharmaceuticals, L.L.C., with name changes recorded on May 15, 2017, and February 18, 2011.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.